The Pedigree Rate of Sequence Divergence in the Human Mitochondrial Genome: There Is a Difference Between Phylogenetic and Pedigree Rates  by Howell, Neil et al.
Am. J. Hum. Genet. 72:659–670, 2003
659
The Pedigree Rate of Sequence Divergence in the Human Mitochondrial
Genome: There Is a Difference Between Phylogenetic and Pedigree Rates
Neil Howell,1,2,3 Christy Bogolin Smejkal,3 D. A. Mackey,4 P. F. Chinnery,5 D. M. Turnbull,5
and Corinna Herrnstadt1
1MitoKor, San Diego; Departments of 2Radiation Oncology and 3Human Biological Chemistry and Genetics, The University of Texas Medical
Branch, Galveston; 4Centre for Eye Research Australia, Royal Victoria Eye and Ear Hospital, Melbourne; 5Department of Neurology,
The University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
We have extended our previous analysis of the pedigree rate of control-region divergence in the humanmitochondrial
genome. One new germline mutation in the mitochondrial DNA (mtDNA) control region was detected among 185
transmission events (generations) from five Leber hereditary optic neuropathy (LHON) pedigrees. Pooling theLHON
pedigree analyses yields a control-region divergence rate of 1.0 mutation/bp/106 years (Myr). When the results
from eight published studies that used a similar approach were pooled with the LHON pedigree studies, totaling
12,600 transmission events, a pedigree divergence rate of 0.95mutations/bp/Myr for the control regionwas obtained
with a 99.5% confidence interval of 0.53–1.57. Taken together, the cumulative results support the original conclusion
that the pedigree divergence rate for the control region is ∼10-fold higher than that obtained with phylogenetic
analyses. There is no evidence that any one factor explains this discrepancy, and the possible roles of mutational
hotspots (rate heterogeneity), selection, and random genetic drift and the limitations of phylogenetic approaches
to deal with high levels of homoplasy are discussed. In addition, we have extended our pedigree analysis of divergence
in the mtDNA coding region. Finally, divergence of complete mtDNA sequences was analyzed in two tissues, white
blood cells and skeletal muscle, from each of 17 individuals. In three of these individuals, there were four instances
in which an mtDNA mutation was found in one tissue but not in the other. These results are discussed in terms
of the occurrence of somatic mtDNA mutations.
Introduction
The noncoding control region, or D-loop, of the human
mitochondrial genome (mtDNA) continues to be widely
used to “time” human evolution and population move-
ments, both ancient and modern (e.g., see Richards et
al. 2000; Bandelt et al. 2001; Torroni et al. 2001a).
Many of these studies continue to rely on phylogenetic
analyses of mtDNA-control-region haplotype trees and
phylogenetically derived rates of divergence, despite the
complications that arise from the effects of marked site
variability in the control region (Excoffier and Yang
1999; Meyer et al. 1999; Heyer et al. 2001), a high rate
of parallel mutations (homoplasy; e.g., see fig. 1 of article
by Bandelt et al. [2001]), evidence for violations of
clocklike evolution (Ingman et al. 2000; Torroni et al.
2001b) and of nonneutral evolution (Gerber et al. 2001;
Rand 2001), and the failure of most phylogenetic ap-
proaches to factor in the effects of population dynamics,
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admixture, and migration (Rannala and Bertorelle
2001; Relethford 2001). One approach that should
reduce the confounding effects of control-region ho-
moplasy involves analysis of the more slowly diverging
mtDNA coding region (Ingman et al. 2000), although
reduced-median-network analysis of a large set of coding
region sequences revealed parallel mutations at a sub-
stantial number of sites (Herrnstadt et al. 2002a).
In an effort to estimate the human mtDNA-control-
region divergence rate with a nonphylogenetic approach,
we analyzed multiple members of a large matrilineal ped-
igree with Leber hereditary optic neuropathy (LHON
[MIM #535000]) (Howell et al. 1996). At that same
time, Parsons et al. (1997) published their analysis of
control-region divergence in a large number of mother-
offspring cohorts. The two studies obtained the same
result, which was that the pedigree rate of control-re-
gion divergence was ∼10-fold higher than phylogenet-
ically derived rates. Several aspects of these pedigree
studies have been challenged (Macaulay et al. 1997;
Jazin et al. 1998) and defended (Howell and Mackey
1997; Parsons and Holland 1998). Subsequent studies
have also estimated the pedigree divergence rate, but a
consensus has not yet emerged, perhaps because most
individual studies have analyzed relatively small num-
bers of transmission events. The same approach has
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Figure 1 The matrilineal pedigree of the USA2 11778 family with LHON. Filled symbols indicate that the family member is visually affected.
been used for other genetic systems, such as the Y chro-
mosome (e.g., see Heyer et al. 1997; Kayser et al. 2000),
but the interpretation of those results has been more
straightforward.
We address two issues here. The first question is
whether the pedigree rate of divergence differs from the
phylogenetically derived rate. The second issue is that,
if there is a difference, then it becomes important to
provide possible explanations for the discrepancy. In the
present study, we expanded our previous analysis of
control-region divergence in multigeneration LHON
pedigrees. The results of our analyses, as well as those
from other studies, indicate that there is a difference in
the two rates, and we discuss the factors that are most
likely to produce this difference.
Subjects, Material, and Methods
Subjects and DNA Samples
Venous blood samples were obtained from family
members and patients, with informed consent and with
approval by the appropriate institutional oversight bod-
ies. In one set of analyses, the complete mtDNA sequence
was determined for two tissues from a single individual.
For these 17 individuals, DNA was isolated both from
the white blood cell (WBC)/platelet fraction of venous
blood samples and from skeletal muscle biopsy speci-
mens. DNA was isolated from the WBC/platelet fraction
by standard procedures of SDS/proteinase K digestion,
phenol extraction, and ethanol precipitation. Frozen
muscle biopsy specimens were pulverized in liquid ni-
trogen with a mortar and pestle, and DNA was extracted
with QIAamp DNA kits (Qiagen). DNA was then pre-
cipitated with ethanol and resuspended in TE buffer (10
mM Tris-HCl [pH 7.5] and 1 mM EDTA). DNA con-
centrations were determined by use of UV absorption.
DNA Sequencing
All nucleotide changes are based on the L-strand se-
quence of the revised Cambridge Reference Sequence
(rCRS) (Andrews et al. 1999). In the present report, we
consider only single–base pair substitutions, and we omit
contractions/expansions of simple repeat sequences. Se-
quence analysis of the control region (nt 16024–16569
and 1–576) for members of families with LHON was
performed as described in our initial report (Howell et
al. 1996). In brief, the control region is amplified by
PCR, as a set of four overlapping fragments (∼350 bp
each). The fragments were ligated into M13 sequencing
vectors and were transformed intoEscherichia colihosts,
and single-stranded recombinant phage were used for
manual sequencing. In the vast majority of experiments,
10–12 clones were informative for each control-region
fragment, although there were instances (∼5%) in which
fewer clones were analyzed.
A site was classified as heteroplasmic if at least two
M13 subclones carried the same sequence change that
was not present in the pedigree’s consensus control-
Howell et al.: Pedigree Divergence Rate of Human mtDNA 661
region sequence. To rule out a false-positive result, such
as one that might arise from PCR amplification errors,
the relevant site was independently reanalyzed. A het-
eroplasmic mtDNA mutation was classified as authentic
only if reanalysis yielded a result similar to that of the
first analysis, and the mutation was considered to have
arisen in the germline only if at least one primary ma-
ternal relative also carried the sequence change.
We observed numerous instances in which a single
clone carried a change from the consensus control-region
sequence. These sequence changes most likely resulted
from errors that arose during PCR amplification. To as-
sess the likelihood that some instances of authentic
mtDNA heteroplasmy had been overlooked, we ana-
lyzed six mtDNA fragments for which a single clonal
difference was detected. The reanalysis involved inde-
pendent PCR amplification and the sequencing of an
additional 20–35 M13 subclones. None of these six
instances was found to represent authentic mtDNA het-
eroplasmy, and our criteria appear adequate for the iden-
tification of newly arising mtDNA mutations in pedi-
grees. Our approach will not capture heteroplasmic
mutations if the frequency of the minority allele is too
low. When the sequencing approach is used, the “break-
even point” occurs when the minority allele is ∼30%,
so mtDNA mutations below this value are unlikely to
be detected.
Determination of complete mtDNA sequences was
performed by use of an automated approach that was
described in detail elsewhere (Herrnstadt et al. 2002a).
For the complete mtDNA sequences of members of the
TAS1 LHON pedigree, the presence of heteroplasmic
sequence changes was assessed by visual inspection of
the sequencing electropherograms. We have shown that
this approach is sufficiently sensitive to detect hetero-
plasmy if the minor allele is present in 15%–20% of the
mtDNA molecules (Herrnstadt et al. 2002b).
Estimates of Divergence Rates and Statistical Analysis
Divergence rates were calculated by the procedure
used previously (e.g., see Parsons et al. 1997). Rates are
derived from the number of “meioses” or transmission
events, which is the number of cumulative generations
tracing back to the most recent maternal ancestor. We
limit our estimates to the number of newly arising germ-
line mutations (those that show transmission through
multiple generations). The divergence rate (twice the ob-
served mutation rate) is expressed as base pairs per mil-
lion years. In the analyses of other pedigree divergence
rate studies, we make the conservative assumption that
there are 1,122 bp in the noncoding control region, even
in those studies that limit their sequencing analysis to
HVR1 and/or HVR2, the two hypervariable regions. It
is also assumed that there are 20 years per generation.
All newly arising substitutions, both heteroplasmic
and homoplasmic, were included in our divergence-rate
estimates. In contrast, Sigurðardo´ttir et al. (2000) cal-
culated their divergence rate estimate on the basis of
three homoplasmic mutations among 705 transmission
events, although there were also three heteroplasmic
control-region mutations in their pedigrees. The situa-
tion is complicated, and one of these heteroplasmic
mutations (at nt 16111) was homoplasmic in another
branch of the same pedigree. In the present study, we
assume that there was a single origin of this mutation
and a complicated pattern of segregation in the pedigree.
To maintain consistency among the various studies, we
include the other two heteroplasmic mutations (at nt
16239 and at nt 16257) in our calculations of the ped-
igree divergence rate. The inclusion of heteroplasmic mu-
tations in the rate estimate of divergence is addressed
further in the “Discussion” section.
Explanation of our utilization of the data from Ben-
dall et al. (1996) is also necessary. They observed five
heteroplasmic mutations among 85 DZ and 95 MZ twin
pairs, and two of the mutations occurred within a single
twin pair. On the basis of our analyses reported else-
where (Howell and Smejkal 2000), we concluded that
the heteroplasmy at nt 16192 is due to somatic hyper-
mutation, not to a germline mtDNA mutation. There-
fore, we assumed here that there are four newly arising
germline mutations in this cohort. Although the actual
number of meioses is 265, we have made the conser-
vative assumption that these twin pairs represent 360
mitochondrial transmission events.
Many studies use the normal approximation to cal-
culate binomial confidence limits for the estimated diver-
gence rate (e.g., see Cavelier et al. 2000). However, that
approximation underestimates the confidence limits for
the small sample sizes used in most individual studies. In
the present study, exact 99.5% binomial confidence limits
were calculated with either the binconlim software pro-
gram provided by J. Rosenblatt or with a publicly avail-
able program. The two programs gave identical results.
The higher confidence limits were used because of the
comparison of multiple studies (Bonferroni correction).
Results
Control-Region Sequence Analysis of the TAS1 LHON
Pedigree
The TAS1 LHON pedigree carries the 11778 patho-
genic mutation, spans 12 generations, and comprises
∼1,600 family members (Mackey and Buttery 1992).
The control-region sequence for pedigree member VIII-
219, which represents the consensus sequence for this
matrilineal pedigree, carried three sequence changes
from the rCRS: 152 TrC, 263 ArG, and 16093 TrC.
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Table 1
Inheritance of Heteroplasmic Mutations in the USA2 LHON
Pedigree
FAMILY
MEMBER
% MTDNA MOLECULES (NO. OF CLONES
WITH ALLELE/TOTAL NO. ANALYZED)
FOR MUTATION
11778 16270
I-1 33 (18/55) 23 (5/22)
II-1 90 (35/39) 96 (22/23)
II-2 75 (40/53) 80 (4/5)
II-3 51 (23/45) 60 (21/35)
II-4 77 (34/44) 83 (5/6)
II-5 100 (42/42) 100 (7/7)
II-6 93 (37/40) 80 (8/10)
III-1 95 (20/21) 100 (11/11)
III-2 100 (20/20) 100 (4/4)
III-3 86 (18/21) 100 (4/4)
III-4 100 (20/20) 100 (3/3)
III-5 88 (29/33) 100 (5/5)
III-6 63 (22/35) 67 (6/9)
III-7 95 (19/20) 100 (10/10)
III-8 100 (23/23) 100 (12/12)
III-9 100 (35/35) 100 (8/8)
The control-region sequence was determined for a total
of 55 TAS1 LHON family members. There were no
newly arising mutations in the control region that
showed evidence of germline transmission and which
would be included in our calculations of the divergence
rate. However, we did observe an example of mtDNA
“hypermutation” or “persistent heteroplasmy” (Howell
and Smejkal 2000; Tully et al. 2000).
In family member VIII-219, the 16093 TrC poly-
morphism was classified as homoplasmic because it was
present in all 11 clones sequenced and analyzed for this
region. However, we detected low-level heteroplasmy at
this site in 16 of the 55 (∼ 30%) family members. For
those 16 individuals, the typical result was that one or
two clones carried a T at nt 16093 (rCRS allele) versus
a C (non-rCRS allele). This heteroplasmy was repro-
duced in independent reanalysis. For example, in the first
analysis of family member VIII-195, 1 of 12 clones car-
ried on the 16093T allele. The numbers in the first and
second repeat analyses were 1/40 and 3/52, respectively.
Overall, 5 of 104 clones analyzed (5%) carried the
16093T allele in this family member. In contrast, family
member IX-158 was 1 of the 39 family members (of a
total of 55) who were classified as homoplasmic for the
16093C allele in the initial sequencing experiments, be-
cause none of the 11 clones analyzed carried the 16093T
allele. An additional 57 clones were sequenced, and 3
of these carried the 16093T allele. That is, this individual
was actually heteroplasmic at this site, although this con-
dition was “missed” initially. Whether heteroplasmy at
this site occurs in all family members is not known.
We have also confirmed persistent heteroplasmy at this
site in other mtDNAs that carry the 16093C allele (data
not shown). Taken together, these results indicate that,
when an mtDNA molecule carries a C at nt 16093, there
is a high probability of reversion or back-mutation to a
T residue (hypermutation). The probability of reversion
is sufficiently high that a large proportion of individuals,
perhaps all, who carry mtDNA with the 16093 TrC
polymorphism will be heteroplasmic. While the present
studies were in progress, Tully et al. (2000) also obtained
evidence for hypermutation of the 16093C allele.
Control-Region Sequence Analysis of the USA2 LHON
Pedigree
The USA2 LHON pedigree is heteroplasmic for the
11778 LHON mutation (Howell et al. 1994). The ped-
igree spans three generations and comprises 16 family
members (fig. 1). Previous analysis of this pedigree in-
dicated hypermutation at nt 16192 (Howell and Smejkal
2000). The complete mtDNA sequence of family mem-
ber II-1 has been determined, and the following coding
region polymorphisms were observed: 750 ArG, 1438
ArG, 1721 CrT, 2706 ArG, 2757 ArG, 3197 TrC,
3212 CrT, 4732 ArG, 4769 ArG, 4843 CrT, 7028
CrT, 7768 ArG, 8860 ArG, 9477 GrA, 11467 ArG,
11719 GrA, 12308 ArG, 12372 GrA, 13617 TrC,
13637 ArG, 14182 TrC, 14766 CrT, 14956 TrC,
and 15326 ArG. This mtDNA belongs to a subcluster
of European haplogroup U. The control-region sequence
includes the following sequence changes: 73 ArG, 150
CrT, 263 ArG, 16189 TrC, 16192 CrT, and 16398
GrA (sequence 0204 in fig. 3 of article by Howell and
Smejkal [2000]).
We have subsequently determined the control-region
sequences for all 16 family members. This analysis re-
vealed that this family was heteroplasmic for site 16270
in HVR1 (table 1). In the matrilineal founder of this
pedigree, 17 of 22 clones carried the 16270 T allele (non-
rCRS), and 5 clones (23%) carried the 16270 C allele
(rCRS). Low levels of the 16270T allele were detected
in five of the six members of generation II but in only
one of the nine members of generation III (fig. 1). For
generation II family members, 61 of 80 clones (76%)
carried the 16270 C allele, whereas 63 of 66 clones
(95%) analyzed for generation III family members car-
ried this allele. This difference between generations is
statistically significant ( ), as determined withP  .01
Fisher’s exact test. The presence of the 16270T allele in
phylogenetically related lineages (Howell and Smejkal
2000) indicates that the USA2 LHON mtDNA has un-
dergone a back-mutation to the CRS allele at this site.
There was a noticeable correlation between the WBC
mutation loads of the 16270 C allele and the 11778 A
pathogenic allele among the USA2 family members
(table 1). This correlation was also observed for multiple
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tissues from the same individual (data not shown). The
simplest explanation of these results is that the 16270
TrC and 11778 GrA mutations occurred within the
same “founder” mtDNA molecule.
Control-Region Sequence Analysis of the NSW8 14482
LHON Pedigree
The pedigree of the NSW8 14482 LHON family and
the complete mtDNA sequence of family member VIII-
20 were reported elsewhere (Howell et al. 1998). This
mtDNA belongs to European haplogroup I, and the con-
trol region from this individual’s mtDNA contained the
following sequence changes: 73 ArG, 199 TrC, 204
TrC, 250 TrC, 263 ArG, 16129 GrA, 16172 TrC,
16223 CrT, 16311 TrC, 16391 GrA, and 16519 TrC.
We have analyzed control-region sequences for eight
family members. No newly arising mtDNA changes were
detected.
Control-Region Sequence Analysis of the QLD1
416014484 Pedigree
The QLD1 family expresses LHON, as well as a num-
ber of severe clinical abnormalities, including dysarthria,
ataxia, tremor, skeletal deformities, and a fatal infantile
encephalopathy (Wallace 1970; see fig. 1 of our earlier
report [Howell et al. 1991] for a partial pedigree). The
mtDNA from this family was found to carry the 14484
LHON mutation and a second pathogenic mutation at
nt 4160 (Howell et al. 1991, 1995). A partial coding-
region sequence for this mtDNA has been determined
(Howell et al. 1991), and the presence of polymorphisms
at nt 4646, 11332, and 12372 indicates that this mtDNA
belongs to European haplogroup U4 (see table 1 of ar-
ticle by Herrnstadt et al. [2002a]). The following se-
quence changes in the control region were detected: 73
ArG, 152 TrC, 263 ArG, 16134 CrT, 16356 TrC,
and 16519 TrC. Control-region sequence was deter-
mined for 11 QLD1 family members, and no newly aris-
ing mutations were detected.
Control-Region Sequence Analysis of the ENG1 11778
LHON Pedigree
This LHON family comprises ∼75 maternally related
individuals and spans six generations (fig. 2). In addition
to this “main” pedigree, a small LHON family (desig-
nated “A” for reasons of geographical association) has
been found that also carries the 11778 LHON mutation
and that has the identical control-region sequence (fig.
3). A genealogical linkage of these two LHON families
has not been established, but one is suspected (P.F.C.,
unpublished data). Molecular genetic evidence now es-
tablishes that the “A” family is an authentic branch of
the ENG1 mtDNA lineage, and those results will be
described below in the “Pedigree Divergence Rate of the
Coding Region” section.
The ENG1 control-region sequence was published
earlier (Howell et al. 1995), and it carries the following
polymorphisms: 73 ArG, 150 CrT, 152 TrC, 263
ArG, 295 CrT, 489 TrC, 16069 CrT, 16126 TrC,
16193 CrT, and 16278 CrT. This array of polymor-
phisms indicates that this mtDNA belongs to European
haplogroup J. A total of 15 family members have been
analyzed here: 9 from the main branch and 6 from the
“A” branch; a conservative total of 26 transmission
events has been assumed. No newly arising mutations
were detected in the control region.
Meta-Analysis of Pedigree Divergence Rates
In our initial study (Howell et al. 1996), we detected
two new germline mtDNA mutations (at HVR2 nt 152
and 195) in the TAS2 LHON family (a total of 88 trans-
mission events), which yielded a control-region diver-
gence rate of 1.9 mutations/bp/Myr (table 2). In the pres-
ent study, one new mutation was observed among a total
of 185 transmission events for the five families with
LHON analyzed here. This number yields a divergence
rate of 0.45 mutations/bp/Myr, a value that is within the
confidence interval of the initial study. When we pool
these results, we obtain a pedigree divergence rate of 1.0
mutations/bp/Myr for the control region (table 2). In
other words, one should detect ∼1 mutation per 90
transmission events.
A number of other groups have used a similar ap-
proach to estimate the pedigree divergence rate in the
control region (table 2). The 99.5% CIs for all data sets
overlap, and we have therefore pooled the results to
obtain a control-region pedigree divergence rate of 0.95
mutations/bp/Myr, a result that is essentially identical to
the rate obtained for the LHON pedigrees. We used
99.5% CIs because of the multiple comparisons but
found that use of 95% CIs had remarkably little effect
on the results. With the more relaxed statistical limits,
only one of the pairwise comparisons (Cavelier et al.
2000 compared with Parsons and Holland 1998) had
nonoverlapping CIs, but this is a result that would be
expected by chance alone.
A control-region divergence rate of 0.95 mutations/
bp/Myr is ∼10 times higher than the phylogenetically
derived divergence rates for this region of the human
mitochondrial genome. For example, estimates of 0.118
mutations/bp/Myr (Stoneking et al. 1992), 0.087 mu-
tations/bp/Myr (Tamura and Nei 1993), and 0.098 mu-
tations/bp/Myr (Hasegawa et al. 1993) have been ob-
tained, with 95% CIs of 0.056–0.18, 0.025–0.15, and
0–0.22, respectively.
These estimates of the pedigree divergence rate will
be biased conservatively because of three factors: (1)
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Figure 2 A partial matrilineal pedigree of the ENG1 11778 family with LHON. The complete pedigree contains too many members to
be conveniently shown. As a result, the numbers used to denote individual family members are not consecutive within a generation. When the
family member numbers are underlined and italicized, the mtDNA control region from these family members was analyzed. Filled symbols
indicate that the family member is visually affected.
most studies limit their analyses to one or both of the
hypervariable regions rather than the complete control
region (table 2); (2) the approaches used will not capture
newly arising heteroplasmic mutations whose allele pro-
portions are 20%; and (3) the pedigree rate is calcu-
lated on the basis of the number of transmission events,
and many family members are not directly analyzed (e.g.,
see Heyer et al. [2001] analyze 61 control-region se-
quences that represent a total of 508 transmission
events). There will be a countervailing inflation of the
pedigree rate if a large proportion of the mutations are
somatic rather than germline. The issue of somatic
mtDNA mutations is one that is further considered in
the “Discussion” section.
Pedigree Divergence Rate of the Coding Region
The related issue of the pedigree divergence rate in
the mtDNA coding region was raised in our initial anal-
ysis (Howell et al. 1996), and those fragmentary data
suggested that this rate might also be higher than the
phylogenetically derived rate. Other results do not sup-
port a higher pedigree rate of coding region divergence.
Thus, Cavelier et al. (2000) sequenced a 500-bp frag-
ment of the coding region, and they did not observe any
newly arising mutations among a total of 194 individ-
uals from 33 matrilineal pedigrees. To provide robust
information on this issue will require much more se-
quence information than is currently available. Never-
theless, we present here some results of additional in-
vestigation of the coding-region divergence rate.
In the majority of branches of the TAS1 LHON family,
penetrance attains a level in line with other Australian
LHON pedigrees. However, there are branches that have
a low penetrance and others that have atypically high
penetrance (Howell and Mackey 1998). Coding region
sequences were analyzed for the following family mem-
bers: VIII-273, normal penetrance; X-22, low penetrance
branch L1; VIII-137 and VIII-138, low penetrance
branch L2; IX-149, high penetrance branch H1; and
VIII-219, high penetrance branch H2 (the branches are
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Figure 3 Pedigree of the “A” branch of the ENG1 family with
LHON. Although this pedigree cannot be definitively linked genea-
logically to the main ENG1 pedigree, sequencing analyses of coding
region polymorphisms (described in the text) show that this is an
authentic branch of the pedigree. When the family member numbers
are underlined and italicized, the control region was analyzed. Filled
symbols indicate that the family member is visually affected.
designated according to criteria reported elsewhere
[Howell and Mackey 1998]). The coding region for all
six family members carried the following polymor-
phisms: 750 ArG, 1438 ArG, 4626 ArG, 4769 ArG,
8860 ArG, 11778 GrA, 11788 CrT, 15317 GrA, and
15326 ArG. There were no additional sequence changes
in any of the TAS1 mtDNAs, homoplasmic or hetero-
plasmic, irrespective of the penetrance. Therefore, the
different levels of penetrance in the branches of the
11778 TAS1 family are not caused by secondary mtDNA
mutations in certain branches of the pedigree.
We have now completed the mtDNA sequence anal-
ysis of the ENG1 LHON pedigree for a family member
from the main branch of the pedigree, and it carries the
following coding region polymorphisms in addition to
the LHON mutation at nt 11778: 750 ArG, 1438 ArG,
2706 ArG, 4216 TrC, 4769 ArG, 5471 GrA, 5633
CrT, 7028 CrT, 7476 CrT, 8860 ArG, 10172 GrA,
10398 ArG, 11251 ArG, 11719 GrA, 12612 ArG,
13708 GrA, 14569 GrA, 14766 CrT, 15257 GrA,
15326 ArG, 15452 CrA, and 15812 GrA. The poly-
morphism at nt 14569 is associated with a branch of
haplogroup J2 (see the network in fig. 4 of the article
by Herrnstadt et al. [2002a]). The mtDNA from family
members of the “A” LHON family (fig. 3) also carry
this polymorphism, a result that supports a close genetic
relationship. In addition, we observed that the ENG1
mtDNA carries a polymorphism at nt 5471. More than
100 haplogroup J mtDNAs have been screened, includ-
ing 6 mtDNAs from the 14569 subcluster, and only the
ENG1 mtDNA carries the 5471 polymorphism (data not
shown). Sequence analysis of two members of the “A”
branch shows that they carry the 5471 polymorphism,
and therefore this family is an authentic branch of the
ENG1 LHON pedigree. One of the two visually affected
members of the “A” branch family (fig. 3) was homo-
plasmic for both the 11778 and 5471 sequence changes.
In contrast, his unaffected maternal great-aunt (fig. 3)
is heteroplasmic at both sites, and the allele ratios are
essentially identical. These results suggest that both cod-
ing region mutations arose simultaneously in the same
mtDNA “founder” molecule. Analysis of other family
members confirms that the 5471 mutation has arisen in
the germline and is segregating in this maternal lineage
(N.H., unpublished data).
The cumulative coding region data presented here can
be combined with those published elsewhere (Howell et
al. 1996), to derive a preliminary estimate of the pedigree
divergence rate. Excluding the LHON mutations, the
rate of newly arising germline mutations in the coding
region is as follows: TAS1, 0 mutations/107 transmission
events; ENG1, 1 mutation/26 transmission events; USA1,
1 mutation/11 transmission events; NWC1, 1 mutation/
9 transmission events; and QLD1, 1 mutation/17 trans-
mission events. Thus, there are 4 coding region muta-
tions/170 transmission events, or ∼0.15 mutations/bp/
Myr (99.5% CI 0.02–0.49). This rate is ∼100-fold
higher than the phylogenetically derived rate (see also
Howell et al. 1996). If we pool our results with those
of Cavelier et al. (2000), we obtain 4 mutations/462
transmission events, or a rate of 0.06 mutations/bp/Myr
(99.5% CI 0.008–0.20), which is ∼30 times higher than
the phylogenetic rate. This rate should be conservative
because it is based on partial sequencing of the coding
region, but there may be factors that bias the rate esti-
mate in the opposite direction.
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Table 2
Estimates of Pedigree Divergence Rates
Data Set
Region
Analyzed
No. of Mutations/
Generations
Divergence
Ratea 99.5% CI
Present study Control 1/185 .48 .00–3.87
Howell et al. 1996 Control 2/88 1.90 .07–9.20
Pooled (UTMB)b Control 3/263 1.02 .09–3.97
Bendall et al. 1996 HVR1 4/360 .99 .14–3.35
Mumm et al. 1997 HVR1 1/59 1.51 .00–11.71
Parsons et al. 1997c HVR1, HVR2 1/32 2.76 .01–20.43
Cavelier et al. 2000 HVR1, HVR2 0/292 .00 .00–1.82
Parsons and Holland 1998 HVR1, HVR2 10/306 2.91 .99–6.44
Soodyall et al. 1997 HVR1, HVR2 0/108 .00 .00–4.79
Sigurðardo´ttir et al. 2000 Controld 5/705 .63 .12–1.90
Heyer et al. 2001 HVR1, HVR2 4/508 .70 .10–2.34
Pooled (All studies) Control 28/2633 .95 .53–1.57
a 2 # (Mutations/control region bp/Myr).
b UTMB p University of Texas Medical Branch.
c These results refer to the analyses at the U.K. Forensic Science Service that were reported
in Parsons et al. (1997).
d The mtDNA region sequenced spanned nt 16012 through 394. That is, this region spanned
more than HVR1 and HVR2, but it did not include ∼180 bp at one end of the control region.
Table 3
mtDNA Discrepancies between
Blood and Muscle
mtDNA
Sequencea Muscle Blood
145/M  16311/100
149/L1a  6257/100
140/L3d 10646/50 
 16093/100
152/J 185/25b 185/100
147/W 9145/30 9145/95
9198/30 9198/80
a The sequences are listed by the
number used in Herrnstadt et al.
(2002a). The haplogroup affiliation is
also included.
b The first number is the nucleotide
position at which these polymor-
phisms occur (all are transitions), and
the second number is the allele pro-
portion (as a percentage) of the non-
rCRS allele. A minus () indicates that
the polymorphism was not detected in
the tissue analyzed.
mtDNA Sequence in Different Tissues from the Same
Individual
To address the issue of somatic versus germline mu-
tations at the pedigree level, we obtained mtDNA se-
quence both from the WBC/platelet fraction of blood
and from skeletal muscle for 17 individuals. The results
for this analysis are presented in table 3. In 12 of these
17 individuals, there were no mtDNA sequence differ-
ences between muscle and blood, and there were no
heteroplasmic sequence changes. However, in two in-
dividuals (sequences 145 and 149), each blood mtDNA
carried a homoplasmic sequence change that was un-
detectable in muscle. Tissue-specific events may repre-
sent somatic mtDNA mutations, even if they are ho-
moplasmic. A similar finding occurred for individual
140, who was also homoplasmic for a control-region
polymorphism that could not be detected in the muscle
of this individual. In addition, this individual carried a
heteroplasmic sequence change in muscle that was not
detected in blood. In a fourth individual (sequence 152),
a control-region polymorphism was apparently homo-
plasmic in blood but heteroplasmic in muscle. Finally,
individual 147 was heteroplasmic at two coding region
sites, and the proportions of the non-rCRS alleles were
clearly higher in blood than in muscle. Furthermore, the
allele proportions for the two sites were similar (cosegre-
gation), and the sites of the mutations were within 45
bp. These two polymorphisms apparently occurred si-
multaneously in a “founder” mtDNA molecule. In ad-
dition, we observed a smaller frequency of heteroplasmic
individuals than did Tully et al. (2000), although the
results are more similar if hypermutation at nt 16093 is
omitted from their analysis.
The mitochondrial genomes of the USA2 LHON ped-
igree, the ENG1 LHON pedigree, and the individual
who carries mtDNA 147 (table 3) all appear to have
undergone “two-hit” mutational events. Two of these
instances involve two coding-region mutations arising
simultaneously, and the third involves one mutation in
the coding region and one in the control region (table
1). The biological significance, if any, of these “two-hit”
events is unclear at present, but they suggest that
mtDNA mutations may not be independent in time.
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Discussion
The results of the present study extend and support the
previous contention that the pedigree rate of human
mtDNA divergence in the control region is higher, by an
order of magnitude, than the rate derived with phylo-
genetic approaches (Howell et al. 1996; Parsons et al.
1997). Although phylogenetic approaches underesti-
mate, to some extent, the control-region divergence rate
(see below), the main issue is the elevated rate of diver-
gence in pedigrees. The available data also indicate that
the pedigree rate of coding region divergence is elevated,
but discussion of this issue is deferred until further data
are obtained.
Let us first consider these two rates in terms of what
we know about human mitochondrial genetics and
what is being measured operationally. An important
point is that mtDNA—to use the terminology of Rand
(2001)—“exists in a nested hierarchy of populations.”
That is, there are population effects at the levels of the
mtDNA molecule, the mitochondrial organelle, the cell,
the tissue, the individual, and the human population.
Both selection and random genetic drift can operate at
each of these population levels (Rand 2001). Starting
at the level of the mtDNA molecule in the female germ-
line, there is an overall mutation rate for substitutions
in the control region (termed “ugerm” here). Both the
pedigree (kped) and the phylogenetic (kphy) divergence
rates must be defined operationally, and kped is defined
here as the rate at which control-region mutations occur
and segregate to a detectable level in a matrilineal ped-
igree. For reasons to be explained below, this termi-
nology is different from that used by Sigurðardo´ttir et
al. (2000).
Both heteroplasmic and homoplasmic mutations, in
this study and in others, have been included in the ped-
igree rate estimate, with the practical limitation that
only those heteroplasmic mutations that have reached
a level of 20%–30% of the mtDNA population will be
detectable. This definition raises the question of whether
the kped/kphy rate difference can be resolved by simply
“counting” only homoplasmic mutants, thereby pre-
suming that most heteroplasmic mutations will not be-
come homoplasmic and/or will not be transmitted at
the level of the population. For example, Bendall et al.
(1996) assume that one-half of heteroplasmic mutations
detected in their pedigree analyses will not become ho-
moplasmic for the “new” allele. That assumption, how-
ever, is not supported by any experimental evidence of
which we are aware, and it does not recognize that the
probability of becoming homoplasmic is almost cer-
tainly a function of allele load. Thus, heteroplasmic mu-
tations that have reached a level of 20%–30%, the min-
imum levels for pedigree analysis of the divergence rate,
should have a much higher probability of becoming
homoplasmic than those that have reached, for exam-
ple, only 1%–2%. Furthermore, even the omission of
one-half of the heteroplasmic mutations would not re-
solve the pedigree/phylogenetic rate difference. The re-
sults of Heyer et al. (2001) are particularly germane.
They have analyzed deep maternal lineages and have
based their divergence rate estimate on control-region
mutations that have arisen within these lineages, all of
which had become homoplasmic. Their estimated di-
vergence rate is ∼30% lower than the rate obtained with
the pooled results (table 2).
Sigurðardo´ttir et al. (2000) also raise the concern that
many heteroplasmic mutations are somatic variants
rather than true germline mutations. However, their
data clearly show that the heteroplasmic mutations in
their lineages were inherited through multiple genera-
tions and therefore that they cannot be somatic. The
requirement for multigeneration transmission was a
specific inclusion criterion for our analyses, and a survey
of the other published studies indicates that inflation of
the estimated kped (table 2) by somatic variants is un-
tenable. Even in the study reported by Parsons et al.
(1997), which analyzed small pedigrees, the newly aris-
ing mutations were detected in multiple family members
and thus cannot be somatic. Somatic mtDNA variants
do occur (table 3; see also Howell et al. 1996), but they
will not limit pedigree analyses if the appropriate in-
clusion criteria are used. On balance, therefore, the use
of heteroplasmic mutations in divergence rate estimates
is appropriate, as long as one understands that the dif-
ferent divergence rates are complex functions of mul-
tiple evolutionary processes and not the measurements
of a single, simple process.
Both kphy and kped will be less than ugerm, and we can
identify some of the multiple factors that are involved
in this “loss of mutations,” although it is not yet pos-
sible to quantify the relative magnitude of their effects.
One major reason that kped will be less than ugerm is that
a proportion of new mutations will not be transmitted
because of the reduction—or bottleneck—in the units
of mtDNA segregation that occurs during oogenesis
(Chinnery et al. 2000; Howell et al. 2000; Jansen 2000).
Selection can also reduce the number of mutations that
are transmitted (e.g., mutations in the control region
that impair replication). Because kped will be a function
both of the mutation rate at the molecular level and the
segregation/transmission processes at the molecular,
organelle, cellular, and individual levels (Howell and
Mackey 1997; Rand 2001), we use a term different from
u, which was defined by Sigurðardo´ttir et al. (2000) as
the mutation rate/individual/generation.
The available results also indicate that kphy will be less
than kped in mitochondrial lineages. Sigurðardo´ttir et al.
(2000) defined ks, the rate at which the population be-
comes fixed for a mutation, and ka, the rate of mutation
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along an ancestral lineage. The terms “ka” and “kphy”
refer to the same rate, but we prefer “divergence” to
“mutation” rate, to allow for the influence of processes
other than mutation. Sigurðardo´ttir et al. (2000) argue
that, under certain conditions of neutral evolution, ka/
kphy and u/kped are “trying to estimate the same thing”
(see their discussion on p. 1607). However, kped will be
larger than kphy as a consequence of several processes,
including both selection and the relative magnitudes of
the mutation rate and the inverse of the effective pop-
ulation size (see also Donnelly 1991). Those conditions,
as we discuss here, are more likely to apply to the human
mitochondrial genome. Before considering selection or
nonneutral evolution, there are two other process that
will tend to reduce kphy relative to kped. In “real” pop-
ulations, even homoplasmic mtDNA mutations will be
lost through the extinction of maternal lineages, and
this process will obviously be a function of the number
of generations. Heyer (1995) has shown that mtDNA
lineages are lost more frequently than nuclear genetic
lineages, even in growing populations and over rela-
tively short timescales. The second effect is the high
mtDNA mutation rate and the relatively small effective
population sizes of mitochondrial genes.
Sigurðardo´ttir et al. (2000) conclude that selection is
unlikely to be a major factor that underlies the dif-
ference between phylogenetic and pedigree divergence
rates, which is not the same thing as saying that selection
does not act on mtDNA. There is substantial evidence
that the evolution of mtDNA is not neutral (reviewed
by Gerber et al. [2001] and Rand [2001]). It has also
been shown that human mtDNA does not obey a mo-
lecular clock (Ingman et al. 2000; Torroni et al. 2001b;
N.H., J. L. Elson, D.M.T., and C.H., unpublished data).
However, it has not been possible to identify which
specific sites in the control region, if any, are subject to
selection. Meyer et al. (1999) have shown both that
control-region domains with no known function can
have low rates of divergence and that functional do-
mains of the mtDNA control region do not have uni-
formly low divergence rates (see their fig. 2 and the
accompanying discussion). Furthermore, site variability
of divergence is not a perfect indicator of which sites
are vulnerable to selection, because sequence context
can act as a determinant of mutation rate (Zavolan and
Kepler 2001). Sorting out the effects of selection on
control-region sites is further complicated by the ab-
sence of recombination in human mtDNA, which
“links” evolution of neutral sites in the control region
to coding region sites that are subject to selection (e.g.,
see Rand 2001).
Some clue as to the relative roles of selection versus
random genetic drift should come from the spectrum of
the mutations that have been identified in pedigree anal-
yses. On the basis of the published information (refer-
ences in table 2), ∼65% of these mutations involve CrT
or TrC changes on the L-strand, whereas∼35% involve
ArG or GrA changes. The number of mutations an-
alyzed is small, but these proportions are compatible
with the rate estimates for the human mtDNA control
region derived from phylogenetic analyses (e.g., see fig.
2 of article by Tamura [2000]). At this point, the results
suggest that selection has not preferentially distorted the
pedigree mutation spectrum relative to the phylogenetic
one, but more data are needed. In this regard, trans-
mission of pathogenic mtDNA mutations appears to be
determined more by random genetic drift than by se-
lection in mother-offspring transmissions (Chinnery et
al. 2000).
Heyer et al. (2001) have analyzed deep-rooting
French-Canadian maternal lineages, and they derive a
divergence rate (table 2) that is similar to the overall
rate with pooled samples. Furthermore, they concluded
that the pedigree divergence rate is higher than the phy-
logenetic rate because of the stronger effects of rapidly
evolving sites on the former. This proposal has been
made elsewhere (e.g., see Pa¨a¨bo 1996; Macaulay et al.
1997; Jazin et al. 1998), but it is one that is not without
problems (discussed in articles by Howell and Mackey
[1997], Parsons and Holland [1998], and Meyer et al.
[1999]). For example, because of the high frequency of
homoplasy (parallel mutations and reversion), it is dif-
ficult for standard phylogenetic approaches to identify
mutational hotspots (e.g., see table 4 in the article by
Excoffier and Yang [1999]). In fact, one can turn the
argument around and suggest that some fraction of
the disparity in rate estimates results from this lim-
itation of phylogenetic approaches (Howell et al. 1996;
Sigurðardo´ttir et al. 2000). Heyer et al. (2001) attempt
to avoid this limitation through the analysis of substi-
tution-density distributions for the HVR1 and HVR2
segments of the control region among a set of European
mtDNAs. However, their approach requires that the se-
quences have a “starlike” phylogeny, and this is not the
case, except for the main subclusters of haplogroup
H mtDNAs (see fig. 3 in article by Herrnstadt et al.
[2002a]).
The issue of the mtDNA divergence rate has been
studied in animals other than humans. Lambert et al.
(2002) observed that the empirically derived rate of pen-
guin mtDNA-control-region divergence was two to
seven times higher than the phylogenetically derived
rate. Denver et al. (2000) estimated the rate of mtDNA
divergence in mutation accumulation lines of Caenor-
habditis elegans to be 8.9 mutations/site/Myr, a rate that
is ∼100-fold higher than phylogenetically derived di-
vergence rates. The authors obtained no evidence that
mutational hotspots were causing the high rate of di-
vergence. Furthermore, the accumulation lines do not
show the bias toward synonymous substitutions that
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typify the phylogenetic results (see table 1 in the article
by Denver et al. [2000]). On the basis of this obser-
vation, they suggest that selection is a strong force that
has acted, during the evolution of mtDNA, to remove
a substantial proportion of coding region mtDNA mu-
tations before they become fixed at the population level.
In conclusion, the results presented here indicate that
the pedigree rate of control-region divergence is signif-
icantly higher than the phylogenetic divergence rate.
The disparity is unlikely to be caused by a single factor
or evolutionary process, and we suggest that mutational
hotspots, random genetic drift, the inability of phylo-
genetic methods to adequately capture the high levels
of control-region homoplasy, and selection are involved.
Pedigree analyses provide a complementary approach
to phylogenetic analyses that will allow us to more fully
understand the processes that shape the evolution of the
human mitochondrial genome.
Acknowledgments
This work was submitted by C.B.S. to The University of
Texas Medical Branch (UTMB) in partial fulfillment of the
requirements for the degree of Master of Science. This research
was supported, in part, by National Science Foundation grant
BCS-9910871 (to N.H.) and by a Wellcome Collaboration
Grant (to N.H. and D.M.T.). The technical assistance of Iwona
Kubacka (UTMB) is gratefully acknowledged. We also ac-
knowledge the assistance of Drs. Ivan Bodis-Wollner (State
University of New York [SUNY], Health Science Center at
Brooklyn) and Jerome Sherman (SUNY College of Optometry)
in obtaining samples and pedigree information for the USA2
family with LHON. Drs. Jerrold M. Olefsky (University of
California, San Diego) and Christen Anderson (MitoKor) pro-
vided the matched blood and muscle samples. Finally, we thank
Dr. Judah Rosenblatt (UTMB), for his assistance with the
statistical analyses of divergence rates, and Dr. Joanna Elson
(University of Newcastle), for her assistance with Fisher’s exact
tests and for her comments on earlier versions of the
manuscript.
Electronic-Database Information
The accession number and URL for data presented herein
are as follows:
Exact Binomial and Poisson Confidence Intervals, http://
members.aol.com/johnp71/confint.html
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for LHON [MIM #535000])
References
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turn-
bull DM, Howell N (1999) Reanalysis and revision of the
Cambridge reference sequence for human mitochondrial
DNA. Nat Genet 23:147
Bandelt H-J, Alves-Silva J, Guimaraes PEM, Santos MS, Brehm
A, Pereira L, Coppa A, Larruga JM, Rengo C, Scozzari R,
Torroni A, Prata MJ, Amorim A, Prado VF, Pena SDJ (2001)
Phylogeography of the human mitochondrial haplogroup
L3e: a snapshot of African prehistory and Atlantic slave
trade. Ann Hum Genet 65:549–563
Bendall KE, Macaulay VA, Baker JR, Sykes BC (1996) Het-
eroplasmic point mutations in the human mtDNA control
region. Am J Hum Genet 59:1276–1287
Cavelier L, Jazin E, Jalonen P, Gyllensten U (2000) mtDNA
substitution rate and segregation of heteroplasmy in coding
and noncoding regions. Hum Genet 107:45–50
Chinnery PF, Thorburn DR, Samuels DC, White SL, Dahl H-
HM, Turnbull DM, Lightowlers RN, Howell N (2000) The
inheritance of mitochondrial DNA heteroplasmy: random
drift, selection or both? Trends Genet 16:500–505
Denver DR, Morris K, Lynch M, Vassilieva LL, Thomas WK
(2000) High direct estimate of the mutation rate in the mi-
tochondrial genome of Caenorhabditis elegans. Science 289:
2342–2344
Donnelly P (1991) Comment on the growth and stabilization
of populations. Stat Sci 6:277–279
Excoffier L, Yang Z (1999) Substitution rate variation among
sites in mitochondrial hypervariable region I of humans and
chimpanzees. Mol Biol Evol 16:1357–1368
Gerber AS, Loggins R, Kumar S, Dowling TE (2001) Does
nonneutral evolution shape observed patterns of DNA var-
iation in animal mitochondrial genomes? Ann Rev Genet
35:539–566
Hasegawa M, DiRenzo A, Kocher TD, Wilson AC (1993) To-
ward a more accurate estimate for the human mitochondrial
DNA tree. J Mol Evol 37:347–354
Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM,
Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE,
Howell N (2002a) Reduced-median-network analysis of
complete mitochondrial DNA coding-region sequences for
the major African, Asian, and European haplogroups. Am
J Hum Genet 70:1152–1171
Herrnstadt C, Preston G, Andrews R, Chinnery PF, Lightow-
lers R, Turnbull DM, Kubacka I, Howell N (2002b) A high
frequency of polymorphisms in HeLa cell sublines. Mutat
Res 501:19–28
Heyer E (1995) Mitochondrial and nuclear genetic contribu-
tion of female founders to a contemporary population in
northeast Quebec. Am J Hum Genet 56:1450–1455
Heyer E, Puymirat J, Dieltjes P, Bakker E, de Knijff P (1997)
Estimating Y chromosome specific microsatellite mutation
frequencies using deep rooting pedigrees. Hum Mol Genet
6:799–803
Heyer E, Zietkiewicz E, Rochowski A, Yotova V, Puymirat J,
Labuda D (2001) Phylogenetic and familial estimates of mi-
tochondrial substitution rates: study of control region mu-
tations in deep-rooting pedigrees. Am J Hum Genet 69:
1113–1126
Howell N, Bogolin C, Jamieson R, Marenda DR, Mackey DA
(1998) mtDNA mutations that cause optic neuropathy: how
do we know? Am J Hum Genet 62:196–202
Howell N, Chinnery PF, Ghosh SS, Fahy E, Turnbull DM
(2000) Transmission of the human mitochondrial genome.
Hum Reprod Suppl 15:235–245
Howell N, Kubacka I, Halvorson S, Howell B, McCullough
670 Am. J. Hum. Genet. 72:659–670, 2003
DA, Mackey D (1995) Phylogenetic analysis of the mito-
chondrial genomes from Leber hereditary optic neuropathy
pedigrees. Genetics 140:285–302
Howell N, Kubacka I, Mackey DA (1996) How rapidly does
the human mitochondrial genome evolve? Am J Hum Genet
59:501–509
Howell N, Mackey DA (1997) Reply to Macaulay et al. Am
J Hum Genet 61:986–990
——— (1998) Low-penetrance branches in matrilineal pedi-
grees with Leber hereditary optic neuropathy. Am J Hum
Genet 63:1220–1224
Howell N, Smejkal CB (2000) Persistent heteroplasmy of a
mutation in the human mtDNA control region: hypermu-
tation as an apparent consequence of simple-repeat expan-
sion/contraction. Am J Hum Genet 66:1589–1598
Howell N, Kubacka I, Xu M, McCullough DA (1991) Leber
hereditary optic neuropathy: involvement of the mitochon-
drial ND1 gene and evidence for an intragenic suppressor
mutation. Am J Hum Genet 48:935–942
Howell N, Xu M, Halvorson S, Bodis-Wollner I, Sherman J
(1994) A heteroplasmic LHON family: tissue distribution
and transmission of the 11778 mutation. Am J Hum Genet
55:203–206
Ingman M, Kaessmann H, Pa¨a¨bo S, Gyllensten U (2000) Mi-
tochondrial genome variation and the origin of modern hu-
mans. Nature 408:708–712
Jansen RPS (ed) (2000) The bottleneck: gamete and embryo
mitochondria in humans. Hum Reprod volume 15, supple-
ment 2
Jazin E, Soodyall H, Jalonen P, Lindholm E, Stoneking M,
Gyllensten U (1998) Mitochondrial mutation rate revisited:
hot spots and polymorphism. Nat Genet 18:109–110
Kayser M, Roewer L, Hedman M, Henke L, Henke J, Brauer
S, Kruger C, Krawczak M, Nagy M, Dobosz T, Szibor R,
de Knijff P, Stoneking M, Sajantila A (2000) Characteristics
and frequency of germline mutations at microsatellite loci
from the human Y chromosome, as revealed by direct
observation in father/son pairs. Am J Hum Genet 66:
1580–1588
Lambert DM, Ritchie PA, Millar CD, Holland B, Drummond
AJ, Baroni C (2002) Rates of evolution in ancient DNA from
Ade´lie penguins. Science 295:2270–2273
Macaulay VA, Richards MB, Forster P, Bendall KE, Watson
E, Sykes BC, Bandelt H-J (1997) mtDNA mutation rates:
no need to panic. Am J Hum Genet 61:983–986
Mackey DA, Buttery RG (1992) Leber hereditary optic neu-
ropathy in Australia. Aust N Z J Ophthalmol 20:177–184
Meyer S, Weiss G, von Haeseler A (1999) Pattern of nucleotide
substitutions and rate heterogeneity in the hypervariable
regions I and II of human mtDNA. Genetics 152:1103–1110
Mumm S, Whyte MP, Thakker RV, Buetow KH, Schlessinger
D (1997) mtDNA analysis shows common ancestry in two
kindreds with X-linked recessive hypoparathyroidism and
reveals a heteroplasmic silent mutation. Am J Hum Genet
60:153–159
Pa¨a¨bo S (1996) Mutational hot spots in the mitochondrial
microcosm. Am J Hum Genet 59:493–496
Parsons TJ, Holland MM (1998) Mitochondrial mutation rate
revisited: hot spots and polymorphism. Nat Genet 18:110
Parsons TJ, Muniec DS, Sullivan K, Woodyatt N, Alliston-
Grenier R, Wilson MR, Berry DL, Holland KA, Weedn VW,
Gill P, Holland MM (1997) A high observed substitution
rate in the human mitochondrial DNA control region. Nat
Genet 15:363–368
Rand DM (2001) The units of selection on mitochondrial
DNA. Ann Rev Ecol Syst 32:415–448
Rannala B, Bertorelle G (2001) Using linked markers to infer
the age of a mutation. Hum Mutat 18:87–100
Relethford JH (2001) Ancient DNA and the origin of modern
humans. Proc Natl Acad Sci USA 98:390–391
Richards M, Macaulay V, Hickey E, Vega E, Sykes B, Guida
V, Rengo C, et al (2000) Tracing European founder lineages
in the Near Eastern mtDNA pool. Am J Hum Genet 67:
1251–1277
Sigurðardo´ttir S, Helgason A, Gulcher JR, Stefansson K, Don-
nelly P (2000) The mutation rate in the human mtDNA
control region. Am J Hum Genet 66:1599–1609
Soodyall H, Jenkins T, Mukherjee A, Du Toit E, Roberts DF,
Stoneking M (1997) The founding mitochondrial DNA
lineages of Tristan da Cunha. Am J Phys Anthropol 104:
157–166
Stoneking M, Sherry ST, Redd AJ, Vigilant L (1992) New
approaches to dating suggest a recent age for the human
mtDNA ancestor. Philos Trans R Soc London B Biol Sci 337:
167–175
Tamura K (2000) On the estimation of the rate of nucleotide
substitution for the control region of human mitochondrial
DNA. Gene 259:189–197
Tamura K, Nei M (1993) Estimation of the number of nucle-
otide substitutions in the control region of mitochondrial
DNA in humans and chimpanzees. Mol Biol Evol 10:
512–526
Torroni A, Bandelt H-J, Macaulay V, Richards M, Cruciani F,
Rengo C, Martinez-Cabrera V, et al (2001a) A signal, from
human mtDNA, of postglacial recolonization in Europe. Am
J Hum Genet 69:844–852
Torroni A, Rengo R, Guida V, Cruciani F, Sellitto D, Coppa
A, Calderon FL, Simionati B, Valle G, Richards M, Macau-
lay V, Scozzari R (2001b) Do the four clades of the mtDNA
haplogroup L2 evolve at different rates? Am J Hum Genet
69:1348–1356
Tully LA, Parsons TJ, Steighner RJ, Holland MM, Marino
MA, Prenger VL (2000) A sensitive denaturing gradient-gel
electrophoresis assay reveals a high frequency of hetero-
plasmy in hypervariable region 1 of the human mtDNA
control region. Am J Hum Genet 67:432–443
Wallace DC (1970) A new manifestation of Leber’s disease
and a new explanation for the agency responsible for its
unusual pattern of inheritance. Brain 93:121–132
Zavolan M, Kepler TB (2001) Statistical inference of sequence-
dependent mutation rates. Curr Opin Genet Devel 11:
612–615
